Data Bridge Market Research analyses that the dysphagia market was valued at USD 3.05 billion in 2021 and is expected to reach USD 4.62 billion by 2029, registering a CAGR of 5.30% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Analysis and Size

In recent years, the dysphagia market is anticipated to proliferate during the forecast period. According to the World Heart Association, the global incidence rate of stroke is 15 million, with 6 million people dying and another 6 million becoming disabled, resulting in vision loss and speech impairment. As a result, the rising prevalence of stroke-related dysphagia and associated pharyngeal and laryngeal problems is propelling the dysphagia market forward. Cerebrovascular accidents (strokes) are caused by insufficient blood supply (oxygen and nutrients) to the brain.

Read More Info: https://www.databridgemarketresearch.com/reports/global-dysphagia-m...

Dysphagia is a condition in which people have trouble swallowing food. The ability to swallow safely is critical for proper nutrition and hydration as well as preventing food from entering the lungs. Swallowing is a complicated act that requires coordinated muscular activity in three basic phases: oral phase (mouth), pharyngeal phase (throat), and esophageal phase (food tube). Dysphagia is a condition that occurs when one or more of these stages are disrupted. Food texture modifying products and other products such as tubes are used to aid in the swallowing process in dysphagia management.

Drivers

Rising number of people addicted to smoking
The rising number of people addicted to smoking is anticipated to influence the dysphagia market's growth during the forecast period. One of the most serious adverse effects of smoking cigarettes for an extended period of time is dysphagia. While tobacco use kills approximately 6 million people each year, the rising prevalence of oropharyngeal cancer is progressively fueling the expansion of the dysphagia market.

Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of dysphagia market is the rising healthcare expenditure which helps in improving its infrastructure.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the dysphagia market. Additionally, high disposable income and surging demand for dysphagia management in healthcare services and medical facilities will expand the dysphagia market. Along with this, rising geriatric population and continuously changing lifestyle will enhance the market's growth rate.

Competitive Landscape and Dysphagia Market Share Analysis
The dysphagia market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to dysphagia market.

Some of the major players operating in the dysphagia market are:

Dr. Reddy's Laboratories Ltd. (India)
AstraZeneca (UK)
Johnson & Johnson Private Limited (US)
Abbott (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
Mylan N.V. (US)
Teva Pharmaceutical Industries Ltd. (Israel)
Novartis AG (Switzerland)
Sun Pharmaceutical Industries Ltd. (India)
Aurobindo Pharma (India)
Pfizer Inc. (US)
GlaxoSmithKline plc (UK)
Dr. Reddy's Laboratories Ltd. (India)
Cipla Inc. (US)
Zydus Cadila (India)
WOCKHARDT (India)
Lannett (US)
Cook (US)
Fresenius Kabi AG (Germany)
BD (US), Eisai Co., Ltd. (Japan)
About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.